Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parmiani

Showing results (211-220 of 301) with videos related to

Pageof 31
Sort By:
Cancer Research|May 1, 1988
Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytesC Gambacorti-Passerini, L Rivoltini, R Supino, et al.
Tumori|August 31, 1986
Infusion of autologous alloactivated lymphocytes in melanoma patients: toxicity and immunologic monitoringC Gambacorti-Passerini, R Marolda, G Tona, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytesG Fossati, A Balsari, D Taramelli, et al.
Cancer Research|February 24, 2001
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cellsC Castelli, A M Ciupitu, F Rini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized studyG Pizzocaro, L Piva, M Colavita, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1992
Expansion of major histocompatibility complex-restricted antimelanoma cytotoxic T-cell lymphocyte clones with identical T-cell receptor from tumor-infiltrating lymphocytesM Sensi, C Castelli, S Salvi, et al.
European Journal of Immunology|September 1, 1992
Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: role of ICAM-1 defined by antibody blocking and gene transferN Jonjic, S Alberti, S Bernasconi, et al.
Transplantation Proceedings|March 1, 1980
Tumor rejection activity of antigens isolated from the membranes of a methylcholanthrene-induced sarcoma, C-1, bearing alien H-2 antigensL W Law, G C DuBois, M J Rogers, et al.
The Journal of Investigative Dermatology|July 8, 2000
Human melanocytes and melanomas express novel mRNA isoforms of the tyrosinase-related protein-2/DOPAchrome tautomerase gene: molecular and functional characterizationP Pisarra, R Lupetti, A Palumbo, et al.
International Journal of Cancer|August 5, 2000
Murine granulocytes control human tumor growth in SCID miceF Lozupone, F Luciani, M Venditti, et al.
Pageof 31

Showing results (211-220 of 301) with videos related to

Sort By:
Pageof 31
Cancer Research|May 1, 1988
Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytesC Gambacorti-Passerini, L Rivoltini, R Supino, et al.
Tumori|August 31, 1986
Infusion of autologous alloactivated lymphocytes in melanoma patients: toxicity and immunologic monitoringC Gambacorti-Passerini, R Marolda, G Tona, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytesG Fossati, A Balsari, D Taramelli, et al.
Cancer Research|February 24, 2001
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cellsC Castelli, A M Ciupitu, F Rini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized studyG Pizzocaro, L Piva, M Colavita, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1992
Expansion of major histocompatibility complex-restricted antimelanoma cytotoxic T-cell lymphocyte clones with identical T-cell receptor from tumor-infiltrating lymphocytesM Sensi, C Castelli, S Salvi, et al.
European Journal of Immunology|September 1, 1992
Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: role of ICAM-1 defined by antibody blocking and gene transferN Jonjic, S Alberti, S Bernasconi, et al.
Transplantation Proceedings|March 1, 1980
Tumor rejection activity of antigens isolated from the membranes of a methylcholanthrene-induced sarcoma, C-1, bearing alien H-2 antigensL W Law, G C DuBois, M J Rogers, et al.
The Journal of Investigative Dermatology|July 8, 2000
Human melanocytes and melanomas express novel mRNA isoforms of the tyrosinase-related protein-2/DOPAchrome tautomerase gene: molecular and functional characterizationP Pisarra, R Lupetti, A Palumbo, et al.
International Journal of Cancer|August 5, 2000
Murine granulocytes control human tumor growth in SCID miceF Lozupone, F Luciani, M Venditti, et al.
Pageof 31